RNA5SP262

Across TCGA pan-cancer cohorts, RNA5SP262 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNA5SP262 data layer.

The strongest signal is observed in ovarian serous cystadenocarcinoma (OV), where higher RNA5SP262 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNA5SP262 expression acts as an unfavorable survival marker.

OV, STAD, and UCEC are the cancer types where RNA5SP262 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
OV	OS	Tertile	II,III,IV	0.456	0.695	.003	108	view →
STAD	DFS	Tertile	All	0.409	0.740	.001	81	view →
UCEC	OS	Tertile	II,III,IV	0.625	0.862	.011	48	view →
BLCA	OS	Tertile	All	0.204	0.687	.028	18	view →
SKCM	DFS	Tertile	All	0.170	0.728	.008	18	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNA5SP262–OV (OS)

Open the OV breakdown →